首页 > 最新文献

International Journal of Gastroenterology Sciences最新文献

英文 中文
Real-world experience of the Lebanese haemodialysis patient infected with the hepatitis C virus and treated with direct-acting antiviral drugs 黎巴嫩血液透析患者感染丙型肝炎病毒并接受直接作用抗病毒药物治疗的实际经验
Pub Date : 2024-01-01 DOI: 10.33545/26649209.2024.v6.i1a.13
A. Antoine, Nakhoul Mary, S. Joyce
Objective: The introduction of direct-acting antivirals (DAAs) has the potential to make a substantial contribution to HCV eradication within dialysis centers. Our study seek assess effectiveness, safety of oral DAAs, both with and without ribavirin, in the Lebanese hemodialysis population afflicted with HCV. Methods: Patient on hemodialysis infected with hepatitis C virus having either genotype 1 or 4 were treated with DAAs. We conducted an analysis of various data points, including age, gender, year of HCV diagnosis, method of infection, comorbidities, previous treatment history, fibrosis stage, current DAAs treatment. We evaluated the virological response at the end of treatment, and12 weeks after stopping treatment Results: Twenty hemodialysis patients infected with HCV genotype 1 or 4 underwent DAA treatment. The gender ratio was 0.82, with an average age of 46.2 years. The mean duration between diagnosis and treatment was 5.7 years. Half of the patients contracted the virus in dialysis centers, 5% through blood transfusion, and in 45% of cases, the cause remained unknown. Comorbidities were present in 45% of cases, with 35% been treated with Ribavirin and Pegylated Interferon. Seventy percent of patients were genotype 1 (70% 1a, 15% 1b), while 25% had fibrosis
目的:直接作用抗病毒药物(DAAs)的引入有可能为透析中心根除 HCV 做出重大贡献。我们的研究旨在评估口服 DAAs(含或不含利巴韦林)在黎巴嫩感染 HCV 的血液透析人群中的有效性和安全性。方法:感染了基因型 1 或 4 丙型肝炎病毒的血液透析患者接受 DAAs 治疗。我们对各种数据点进行了分析,包括年龄、性别、HCV 诊断年份、感染方式、合并症、既往治疗史、纤维化分期、当前的 DAAs 治疗。我们评估了治疗结束时和停止治疗 12 周后的病毒学应答结果:20名感染了HCV基因型1或4的血液透析患者接受了DAA治疗。性别比例为 0.82,平均年龄为 46.2 岁。从确诊到接受治疗的平均时间为 5.7 年。半数患者在透析中心感染病毒,5%的患者通过输血感染病毒,45%的患者病因不明。45%的病例存在合并症,35%的病例接受过利巴韦林和聚乙二醇干扰素治疗。70%的患者基因型为1(70%为1a,15%为1b),25%的患者纤维化程度小于F2,40%为F2-F3,20%为F4。基因型4患者接受Ombitasvir/Paritaprevir/Ritonavir +/- Ribavirin治疗,基因型1患者接受Ombitasvir/Paritaprevir/Ritonavir-Dasabuvir +/- Ribavirin治疗。12周的持续病毒学应答(SVR)率为95%,有一名患者(5%)因耐受性差在2周后中断治疗。两种基因型、不同纤维化分期或既往治疗史在治疗反应上无明显差异。结论这些研究结果代表了黎巴嫩关于血液透析患者使用 DAAs 治疗 HCV 的首个数据。研究显示,SVR12 率高达 95%,只有 5%的患者出现治疗不耐受。这些真实环境中的结果显示了血液透析中心根除 HCV 的潜力。
{"title":"Real-world experience of the Lebanese haemodialysis patient infected with the hepatitis C virus and treated with direct-acting antiviral drugs","authors":"A. Antoine, Nakhoul Mary, S. Joyce","doi":"10.33545/26649209.2024.v6.i1a.13","DOIUrl":"https://doi.org/10.33545/26649209.2024.v6.i1a.13","url":null,"abstract":"Objective: The introduction of direct-acting antivirals (DAAs) has the potential to make a substantial contribution to HCV eradication within dialysis centers. Our study seek assess effectiveness, safety of oral DAAs, both with and without ribavirin, in the Lebanese hemodialysis population afflicted with HCV. Methods: Patient on hemodialysis infected with hepatitis C virus having either genotype 1 or 4 were treated with DAAs. We conducted an analysis of various data points, including age, gender, year of HCV diagnosis, method of infection, comorbidities, previous treatment history, fibrosis stage, current DAAs treatment. We evaluated the virological response at the end of treatment, and12 weeks after stopping treatment Results: Twenty hemodialysis patients infected with HCV genotype 1 or 4 underwent DAA treatment. The gender ratio was 0.82, with an average age of 46.2 years. The mean duration between diagnosis and treatment was 5.7 years. Half of the patients contracted the virus in dialysis centers, 5% through blood transfusion, and in 45% of cases, the cause remained unknown. Comorbidities were present in 45% of cases, with 35% been treated with Ribavirin and Pegylated Interferon. Seventy percent of patients were genotype 1 (70% 1a, 15% 1b), while 25% had fibrosis <F2, 40% F2-F3, and 20% F4. Patients received Ombitasvir/Paritaprevir/Ritonavir +/- Ribavirin for genotype 4, and Ombitasvir/Paritaprevir/Ritonavir-Dasabuvir +/- Ribavirin for genotype 1. The sustained virological response (SVR) at 12 weeks was 95%, with one patient (5%) discontinuing treatment after 2 weeks due to poor tolerance. No significant differences in treatment response observed in the two genotypes, various fibrosis stages, or prior treatment history. Conclusion: These findings represent the first Lebanese data on HCV treatment using DAAs in hemodialysis patients. The study demonstrates an impressive SVR12 rate of 95%, with only 5% of patients experiencing treatment intolerance. These results in real-life settings show the potential for the eradication of HCV in hemodialysis centers.","PeriodicalId":204371,"journal":{"name":"International Journal of Gastroenterology Sciences","volume":"165 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140521400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Upper limit of normal serum alanine transaminase ALT and correlation with gender and BMI 正常血清丙氨酸转氨酶(ALT)上限与性别、BMI的关系
Pub Date : 2022-01-01 DOI: 10.33545/26649209.2022.v4.i1a.10
Zyad Alali
{"title":"Upper limit of normal serum alanine transaminase ALT and correlation with gender and BMI","authors":"Zyad Alali","doi":"10.33545/26649209.2022.v4.i1a.10","DOIUrl":"https://doi.org/10.33545/26649209.2022.v4.i1a.10","url":null,"abstract":"","PeriodicalId":204371,"journal":{"name":"International Journal of Gastroenterology Sciences","volume":"15 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123319424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Infectious diarrhea, as a current medical and public health problematic 传染性腹泻,作为当前的一个医学和公共卫生问题
Pub Date : 2021-01-01 DOI: 10.33545/26649209.2021.v3.i1a.7
D. Monica
{"title":"Infectious diarrhea, as a current medical and public health problematic","authors":"D. Monica","doi":"10.33545/26649209.2021.v3.i1a.7","DOIUrl":"https://doi.org/10.33545/26649209.2021.v3.i1a.7","url":null,"abstract":"","PeriodicalId":204371,"journal":{"name":"International Journal of Gastroenterology Sciences","volume":"65 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114499358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of anti HBC antibodies in blood donors from different centers in Lebanon 黎巴嫩不同中心献血者中抗HBC抗体的流行情况
Pub Date : 2021-01-01 DOI: 10.33545/26649209.2021.v3.i1a.8
Alkhatib Amani M D, Hallal Marwa B S, Awada Batoul M D, Danach Batoul M D, Hallal Mahmoud M D
{"title":"Prevalence of anti HBC antibodies in blood donors from different centers in Lebanon","authors":"Alkhatib Amani M D, Hallal Marwa B S, Awada Batoul M D, Danach Batoul M D, Hallal Mahmoud M D","doi":"10.33545/26649209.2021.v3.i1a.8","DOIUrl":"https://doi.org/10.33545/26649209.2021.v3.i1a.8","url":null,"abstract":"","PeriodicalId":204371,"journal":{"name":"International Journal of Gastroenterology Sciences","volume":"13 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115326254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Presenting an expert system for early diagnosis of gastrointestinal diseases 提出了一种用于胃肠疾病早期诊断的专家系统
Pub Date : 2019-01-01 DOI: 10.33545/26649209.2019.v1.i1a.4
Mirpouya Mirmozaffari
{"title":"Presenting an expert system for early diagnosis of gastrointestinal diseases","authors":"Mirpouya Mirmozaffari","doi":"10.33545/26649209.2019.v1.i1a.4","DOIUrl":"https://doi.org/10.33545/26649209.2019.v1.i1a.4","url":null,"abstract":"","PeriodicalId":204371,"journal":{"name":"International Journal of Gastroenterology Sciences","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129838267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Post-cholecystectomy vascular and biliary injury resulting in hepatic artery pseudoaneurysm presenting with hemobilia and bile leak- a rare complication and surgical management  胆囊切除术后血管和胆道损伤导致肝动脉假性动脉瘤,表现为胆道出血和胆漏-一种罕见的并发症和外科治疗
Pub Date : 2019-01-01 DOI: 10.33545/26649209.2019.v1.i1a.11
Dr. Aniket Zarkar, B. Kalambe
{"title":"Post-cholecystectomy vascular and biliary injury resulting in hepatic artery pseudoaneurysm presenting with hemobilia and bile leak- a rare complication and surgical management ","authors":"Dr. Aniket Zarkar, B. Kalambe","doi":"10.33545/26649209.2019.v1.i1a.11","DOIUrl":"https://doi.org/10.33545/26649209.2019.v1.i1a.11","url":null,"abstract":"","PeriodicalId":204371,"journal":{"name":"International Journal of Gastroenterology Sciences","volume":"25 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115344373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeted therapy in gastric cancer: Review of literature 胃癌的靶向治疗:文献综述
Pub Date : 2019-01-01 DOI: 10.33545/26649209.2019.v1.i1a.3
Debbagh A, Slimani K, Sbitti Y, M. M, Tanz R, Errihani ., Ichou M
{"title":"Targeted therapy in gastric cancer: Review of literature","authors":"Debbagh A, Slimani K, Sbitti Y, M. M, Tanz R, Errihani ., Ichou M","doi":"10.33545/26649209.2019.v1.i1a.3","DOIUrl":"https://doi.org/10.33545/26649209.2019.v1.i1a.3","url":null,"abstract":"","PeriodicalId":204371,"journal":{"name":"International Journal of Gastroenterology Sciences","volume":"319 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126025512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nipah virus: A Major threat to human 尼帕病毒:对人类的重大威胁
Pub Date : 2019-01-01 DOI: 10.33545/26649209.2019.v1.i1a.2
Sanjita Das, Naveen Kumar
{"title":"Nipah virus: A Major threat to human","authors":"Sanjita Das, Naveen Kumar","doi":"10.33545/26649209.2019.v1.i1a.2","DOIUrl":"https://doi.org/10.33545/26649209.2019.v1.i1a.2","url":null,"abstract":"","PeriodicalId":204371,"journal":{"name":"International Journal of Gastroenterology Sciences","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128571773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Henoch-Schouml;nlein purpura presenting as organic gastric outlet obstruction case report 以器质性胃出口梗阻表现的过敏性紫癜1例报告
Pub Date : 2019-01-01 DOI: 10.33545/26649209.2019.v1.i1a.6
Elena Santori, L. Pettine, P. Adamoli, G. Baratelli
{"title":"Henoch-Schouml;nlein purpura presenting as organic gastric outlet obstruction case report","authors":"Elena Santori, L. Pettine, P. Adamoli, G. Baratelli","doi":"10.33545/26649209.2019.v1.i1a.6","DOIUrl":"https://doi.org/10.33545/26649209.2019.v1.i1a.6","url":null,"abstract":"","PeriodicalId":204371,"journal":{"name":"International Journal of Gastroenterology Sciences","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125615948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Varieties of gastrointestinal bleeding in patients with coronary heart disease 冠心病患者胃肠道出血的种类
Pub Date : 2019-01-01 DOI: 10.33545/26649209.2019.v1.i1a.5
Daminova Lt, Kodirov Sh S, Sheck Ab
{"title":"Varieties of gastrointestinal bleeding in patients with coronary heart disease","authors":"Daminova Lt, Kodirov Sh S, Sheck Ab","doi":"10.33545/26649209.2019.v1.i1a.5","DOIUrl":"https://doi.org/10.33545/26649209.2019.v1.i1a.5","url":null,"abstract":"","PeriodicalId":204371,"journal":{"name":"International Journal of Gastroenterology Sciences","volume":"SE-11 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126576156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Gastroenterology Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1